2
MediBrief | February 2025
GLP-1 AGONISTS: TRANSFORMING DIABETES AND OBESITY CARE
Why Are GLP-1 Receptor Agonists A Game-changer for Type 2 Diabetes?
Dr. Joshua Neumiller explains their benefits, including kidney protection, cardiovascular benefits, and emerging indications for conditions like sleep apnea and Alzheimer's.
MediBrief I.M & ENDOCRINE
Made with FlippingBook - professional solution for displaying marketing and sales documents online